Back to 
AQR Capital Management LLC
AQR Capital Management LLC
HBIO
11 quarters
Position history for AQR Capital Management LLC's holdings in Harvard Bioscience, Inc.
No. AQR Capital Management exited its HBIO (Harvard Bioscience) position in Q3 2025. Its Q2 2025 13F listed 45,706 shares worth $20,285. AQR Capital Management first reported HBIO in Q2 2021 and held it in 8 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$205,000
Total Shares Change
-24,588
Quarter-by-Quarter History
Other major holders of HBIO: Royce & Associates LP, Dimensional Fund Advisors LP, BlackRock Finance, Inc.